| dc.contributor.author | Zapata, Karol | |
| dc.contributor.author | Vélez, Angie D. | |
| dc.contributor.author | Correa, Jorge A. | |
| dc.contributor.author | Carrasco Marín, Francisco | |
| dc.contributor.author | Rojano, Benjamín A. | |
| dc.contributor.author | Franco, Camilo A. | |
| dc.contributor.author | Cortés, Farid | |
| dc.date.accessioned | 2024-09-16T09:56:42Z | |
| dc.date.available | 2024-09-16T09:56:42Z | |
| dc.date.issued | 2024-08-27 | |
| dc.identifier.citation | Zapata, K.; Vélez, A.D.; Correa, J.A.; Carrasco-Marín, F.; Rojano, B.A.; Franco, C.A.; Cortés, F.B. Bioactive Properties and In Vitro Digestive Release of Cannabidiol (CBD) from Tailored Composites Based on Carbon Materials. Pharmaceutics 2024, 16, 1132. https://doi.org/10.3390/pharmaceutics16091132 | es_ES |
| dc.identifier.uri | https://hdl.handle.net/10481/94498 | |
| dc.description.abstract | The use of carriers to improve cannabidiol (CBD) bioavailability during digestion is at the
forefront of research. The main objective of this research was to evaluate CBD bioactivity and develop
CBD composites based on tailored carbon support to improve availability under digestive conditions.
The antioxidant capacity of CBDwas evaluated using spectrophotometricmethods, and anti-proliferative
assays were carried out using human colon carcinoma cells (SW480). Twenty-four composites of CBD +
carbon supports were developed, and CBD desorption tests were carried out under simulated digestive
conditions. The antioxidant capacity of CBD was comparable to and superior to Butylhydrox-ytoluene
(BHT), a commercial antioxidant. CBD reflected an IC-50 of 10,000 mg/L against SW480 cancer cells.
CBD in biological systems can increase the shelf life of lipid and protein foods by 7 and 470 days,
respectively. Finally, acid carbons showed major CBD adsorption related to electrostatic interactions, but
basic carbons showed better delivery properties related to electrostatic repulsion. A tailored composite
was achieved with a CBD load of 27 mg/g with the capacity to deliver 1.1 mg, 21.8 mg, and 4 mg to the
mouth, stomach, and duodenum during 18 h, respectively. This is a pioneering study since the carriers
were intelligently developed to improve CBD release. | es_ES |
| dc.description.sponsorship | “FONDO NACIONAL DE FINANCIAMIENTO PARA LA CIENCIA,
LA TECNOLOGÍA Y LA INNOVACIÓN FRANCISCO JOSÉ DE CALDAS” and “Bionatural
Cosmeticos SAS” through contract No. 112721-275-2023 | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | MDPI | es_ES |
| dc.rights | Atribución 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.subject | Bioavailability | es_ES |
| dc.subject | Bioactivity | es_ES |
| dc.subject | Carbon support | es_ES |
| dc.title | Bioactive Properties and In Vitro Digestive Release of Cannabidiol (CBD) from Tailored Composites Based on Carbon Materials | es_ES |
| dc.type | journal article | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.identifier.doi | 10.3390/pharmaceutics16091132 | |
| dc.type.hasVersion | VoR | es_ES |